Clinical Trials Directory

Trials / Unknown

UnknownNCT01095770

Left Atrial Ablation With Permanent Pacemaker or ImplanTable Loop Recorder Follow-UP

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Eastbourne General Hospital · Academic / Other
Sex
All
Age
16 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is 3 fold:- 1. To compare the efficacy and complication rates of 2 widely used methods, conventional irrigation tip ablation catheter (LASSO) and Ablation Frontiers ablation technology, of AF ablation for PAF. 2. To evaluate the Reveal XT ILR as a long term accurate AF monitoring device as compared to the 'gold standard' DDD pacemaker Holter. 3. To accurately evaluate, by continuous rhythm monitoring for 1 year, the efficacy of AF ablation therapy for PAF.

Conditions

Interventions

TypeNameDescription
PROCEDUREAF Ablation with Ablation Frontiers TechnologyAF Ablation with Ablation Frontiers Technology - PVAC, TVAC and MASC.
PROCEDUREAF Ablation with LASSO catheterAF Ablation with traditional LASSO catheter
DEVICEReveal XTReveal XT implantable loop recorder monitored group
DEVICEPermanent Dual Chamber PacemakerThis group will be monitored with a dual chamber pacemaker with advanced AF monitoring capabilities.

Timeline

Start date
2010-04-01
Primary completion
2012-04-01
Completion
2012-11-01
First posted
2010-03-30
Last updated
2010-03-30

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01095770. Inclusion in this directory is not an endorsement.

Left Atrial Ablation With Permanent Pacemaker or ImplanTable Loop Recorder Follow-UP (NCT01095770) · Clinical Trials Directory